Centiva Capital, LP Acadia Pharmaceuticals Inc Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $312,528 - $400,618	19,150 New	19,150 $360,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $1.31 Million - $1.86 Million	-67,674 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $1.43 Million - $3.13 Million	56,992 Added 533.53%	67,674 $1.75 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $101,532 - $140,498	-2,474 Reduced 18.81%	10,682 $571,000
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $60,530 - $94,734	1,662 Added 14.46%	13,156 $543,000
Q2 2020 Aug 14, 2020	BUY	$39.26 - $52.73 $451,254 - $606,078	11,494 New	11,494 $557,000

281

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.79B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.